Horizon Investments LLC Sells 8,748 Shares of Cigna Group $CI

Key Points

• Horizon Investments LLC trimmed its stake in Cigna by 55.3% in Q4, selling 8,748 shares and retaining 7,062 shares valued at about $1.944 million.
• Insiders Everett Neville and Nicole S. Jones sold 1,719 and 2,307 shares respectively on March 2 at an average price of $288.91, reducing their holdings; insiders now own 0.60% of the company.
• Cigna beat Q estimates (EPS $7.79 vs. $7.60; revenue $68.52B vs. $66.29B), issued FY2026 EPS guidance of 30.350, and carries a consensus "Moderate Buy" rating with an average target of $338.35.

Horizon Investments LLC trimmed its holdings in Cigna Group (NYSE:CI - Free Report) by 55.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,062 shares of the health services provider's stock after selling 8,748 shares during the quarter. Horizon Investments LLC's holdings in Cigna Group were worth $1,944,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Beacon Financial Strategies CORP purchased a new stake in Cigna Group during the 4th quarter valued at about $28,000. Lodestone Wealth Management LLC purchased a new stake in Cigna Group during the 4th quarter valued at about $32,000. Collier Financial purchased a new stake in Cigna Group during the 3rd quarter valued at about $34,000. Activest Wealth Management grew its position in Cigna Group by 1,050.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider's stock valued at $38,000 after purchasing an additional 126 shares during the last quarter. Finally, True Wealth Design LLC grew its position in Cigna Group by 116.4% during the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider's stock valued at $43,000 after purchasing an additional 85 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares of the company's stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company's stock.

Analysts Set New Price Targets

CI has been the topic of several recent analyst reports. The Goldman Sachs Group increased their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the company a "buy" rating in a research report on Monday. Wall Street Zen raised shares of Cigna Group from a "hold" rating to a "buy" rating in a research report on Saturday, February 7th. Sanford C. Bernstein increased their price objective on shares of Cigna Group from $358.00 to $371.00 and gave the company an "outperform" rating in a research report on Tuesday. Royal Bank Of Canada increased their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an "outperform" rating in a research report on Friday, May 1st. Finally, Leerink Partners raised their price target on shares of Cigna Group from $270.00 to $297.00 and gave the company a "market perform" rating in a report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Cigna Group currently has a consensus rating of "Moderate Buy" and an average target price of $338.35.

Cigna Group Stock Performance

Shares of NYSE CI opened at $275.73 on Wednesday. The firm's 50-day moving average price is $274.24 and its 200-day moving average price is $276.50. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market cap of $72.94 billion, a PE ratio of 11.69, a PEG ratio of 0.98 and a beta of 0.30. Cigna Group has a 52-week low of $239.51 and a 52-week high of $338.89.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm's revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts anticipate that Cigna Group will post 30.4 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group's payout ratio is 26.45%.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.